EUVIMEDEUVIMED entdecken
Crossref

Drugs for Parkinson's disease

VSC Fung, MA Hely, G De Moore, JGL Morris

Australian Prescriber · 01.08.2001 · 24 (4) · 92-95

DOI: 10.18773/austprescr.2001.099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian Prescriber, erschienen am 01.08.2001. Verfasst von VSC Fung und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levodopa is the most effective drug available for treating the motor symptoms of idiopathic Parkinson's disease.It is usually combined with a peripheral dopa decarboxylase inhibitor.Early treatment with dopamine agonists can reduce the risk of developing dyskinesia.Dopamine agonists and catechol-O-methyltransferase inhibitors can significantly reduce motor fluctuations.Amantadine reduces the severity of dyskinesia in some patients.No treatment has been proven to delay disease progression.

Zitieren

APA

Fung, V., Hely, M., Moore, G. D., & Morris, J. (2001). Drugs for Parkinson's disease. Australian Prescriber, 24(4), 92-95. https://doi.org/10.18773/austprescr.2001.099

Vancouver

Fung V, Hely M, Moore GD, Morris J. Drugs for Parkinson's disease. Australian Prescriber. 2001;24(4):92-95. doi:10.18773/austprescr.2001.099

BibTeX
@article{Fung2001,
  author = {Fung, VSC and Hely, MA and Moore, G De and Morris, JGL},
  title = {Drugs for Parkinson's disease},
  journal = {Australian Prescriber},
  year = {2001},
  volume = {24},
  number = {4},
  pages = {92--95},
  doi = {10.18773/austprescr.2001.099}
}
Kostenlos starten →